These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6820483)

  • 1. Mesolimbic and mesocortical dopaminergic neurons are necessary for normal exploratory behavior in rats.
    Fink JS; Smith GP
    Neurosci Lett; 1980 Apr; 17(1-2):61-5. PubMed ID: 6820483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesolimbicocortical dopamine terminal fields are necessary for normal locomotor and investigatory exploration in rats.
    Fink JS; Smith GP
    Brain Res; 1980 Oct; 199(2):359-84. PubMed ID: 7417789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anatomical analysis of the involvement of mesolimbocortical dopamine in the locomotor stimulant actions of d-amphetamine and apomorphine.
    Clarke PB; Jakubovic A; Fibiger HC
    Psychopharmacology (Berl); 1988; 96(4):511-20. PubMed ID: 3149775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of infusions of 6-hydroxydopamine into nucleus accumbens and anterolateral hypothalamus induced by 6-hydroxydopamine on the response to dopamine agonists, body weight, locomotor activity and measures of exploration in the rat.
    Winn P; Robbins TW
    Neuropharmacology; 1985 Jan; 24(1):25-31. PubMed ID: 3920545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intra-accumbens dopaminergic grafts on behavioral deficits induced by 6-OHDA lesions of the nucleus accumbens or A10 dopaminergic neurons: a comparison.
    Herman JP; Choulli K; Abrous N; Dulluc J; Le Moal M
    Behav Brain Res; 1988 Jul; 29(1-2):73-83. PubMed ID: 3401324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperactivity and hypoactivity produced by lesions to the mesolimbic dopamine system.
    Koob GF; Stinus L; Le Moal M
    Behav Brain Res; 1981 Nov; 3(3):341-59. PubMed ID: 6796098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system.
    Spyraki C; Fibiger HC; Phillips AG
    Psychopharmacology (Berl); 1983; 79(2-3):278-83. PubMed ID: 6405439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesolimbic dopamine lesions produce an augmented behavioral response to enkephalin.
    Kalivas PW; Bronson M
    Neuropharmacology; 1985 Oct; 24(10):931-6. PubMed ID: 3934576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
    Castall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal and mesolimbic dopaminergic contribution to 3,4-dihydroxyphenylacetic acid sulfate in rat plasma.
    Boudet C; Simon H; Cottet-Emard JM; Dalmaz Y; Peyrin L
    Eur J Pharmacol; 1986 Feb; 121(1):113-8. PubMed ID: 3082654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological evidence for non-dopaminergic mesocortical and mesolimbic neurons in the rat.
    Thierry AM; Deniau JM; Herve D; Chevalier G
    Brain Res; 1980 Nov; 201(1):210-4. PubMed ID: 7417833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of injections of 6-OHDA into either nucleus accumbens septi or frontal cortex on spontaneous and drug-induced activity.
    Joyce EM; Stinus L; Iversen SD
    Neuropharmacology; 1983 Sep; 22(9):1141-5. PubMed ID: 6415508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical lesions of the nucleus accumbens septi in rats: effects on muricide and apomorphine-induced aggression.
    Pucilowski O; Valzelli L
    Behav Brain Res; 1986 Feb; 19(2):171-8. PubMed ID: 2870724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disappearance of hoarding behavior after 6-hydroxydopamine lesions of the mesolimbic dopamine neurons and its reinstatement with L-dopa.
    Kelley AE; Stinus L
    Behav Neurosci; 1985 Jun; 99(3):531-45. PubMed ID: 3939664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats.
    Clarke PB; Wyder KJ; Jakubovic A; Fibiger HC
    Br J Pharmacol; 1990 Mar; 99(3):509-15. PubMed ID: 2110017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial protection by desmethylimipramine of the mesocortical dopamine neurones from the neurotoxic effect of 6-hydroxydopamine injected in ventral mesencephalic tegmentum. The role of noradrenergic innervation.
    Herve D; Studler JM; Blanc G; Glowinski J; Tassin JP
    Brain Res; 1986 Sep; 383(1-2):47-53. PubMed ID: 3094831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased locomotor and investigatory exploration after denervation of catecholamine terminal fields in the forebrain of rats.
    Fink JS; Smith GP
    J Comp Physiol Psychol; 1979 Feb; 93(1):34-65. PubMed ID: 447888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated administration of the neurotensin receptor antagonist SR 48692 differentially regulates mesocortical and mesolimbic dopaminergic systems.
    Azzi M; Betancur C; Sillaber I; Spanagel R; Rostène W; Bérod A
    J Neurochem; 1998 Sep; 71(3):1158-67. PubMed ID: 9721741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective disruption of displacement behaviour by lesions of the mesolimbic dopamine system.
    Robbins TW; Koob GF
    Nature; 1980 Jun; 285(5764):409-12. PubMed ID: 6104303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.